Patients < 65 years (n = 1, 023) | Patients ≥ 65 years (n = 1, 005) | p-value | |
---|---|---|---|
Demographics | |||
Age at survey, years | 50.7 ± 9.2 | 74.1 ± 7.3 | < 0.001 |
Male | 61 | 54 | 0.001 |
Body mass index, kg/m2 | 31.2 ± 6.4 | 28.9 ± 5.4 | < 0.001 |
Diabetes-related characteristics | |||
Age at diabetes diagnosis, years | 48.2 ± 9.2 | 70.1 ± 8.5 | -- |
Duration of diabetes*, months | 18 (9, 36) | 25 (11, 60) | < 0.001 |
HbA1c closest to diabetes diagnosis, % | 7.4 ± 1.1 | 7.4 ± 1.2 | 0.389 |
Most recent HbA1c, % | 6.8 ± 0.9 | 6.8 ± 0.7 | 0.101 |
HbA1c change from diagnosis, % | -0.5 (-6.9, 7.5) | -0.4 (-8.5, 1.5) | 0.189 |
Proportion with most recent HbA1c ≥7% | 31 | 32 | 0.600 |
FBG closest to diagnosis, mmol/L | 9.1 ± 2.8 | 9.0 ± 2.6 | 0.505 |
Most recent FBG, mmol/L | 7.1 ± 1.9 | 7.0 ± 2.0 | 0.824 |
Proportion with most recent FBG ≥7 mmol/L | 21 | 20 | 0.380 |
Other characteristics and comorbidities | |||
Serum creatinine, μmol/L | 85.7 ± 25.5 | 97.7 ± 31.7 | < 0.001 |
LDL-cholesterol, mmol/L | 2.7 ± 2.3 | 2.5 ± 1.3 | 0.019 |
HDL-cholesterol, mmol/L | 1.3 ± 0.5 | 1.4 ± 0.5 | 0.084 |
Triglycerides, mmol/L | 2.1 ± 1.3 | 1.7 ± 0.8 | < 0.001 |
Cardiovascular conditions | 5.2 | 18.3 | < 0.001 |
Ischemic heart disease | 3.5 | 9.4 | < 0.001 |
Myocardial infarction | 1.8 | 4.4 | < 0.001 |
Peripheral vascular disease | 0.9 | 2.1 | 0.027 |
Stroke | 0.6 | 3.9 | < 0.001 |
Microvascular complications | 4.3 | 15.4 | < 0.001 |
Neuropathy | 0.7 | 1.3 | 0.184 |
Retinopathy | 1.1 | 2.0 | 0.105 |
Renal disease | 2.8 | 13.2 | < 0.001 |
Total number of medications | 2 (0, 3) | 3 (1, 6) | < 0.001 |
Patient's living situation | |||
Living with spouse/other family member/alone | 98.8 | 89.1 | < 0.001 |